| SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients D Geers, MC Shamier, S Bogers, G den Hartog, L Gommers, ... Science immunology 6 (59), eabj1750, 2021 | 517 | 2021 |
| Oxidative stress resulting from Helicobacter pylori infection contributes to gastric carcinogenesis LD Butcher, G den Hartog, PB Ernst, SE Crowe Cellular and molecular gastroenterology and hepatology 3 (3), 316-322, 2017 | 201 | 2017 |
| mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial SF Oosting, AAM van der Veldt, CH GeurtsvanKessel, RSN Fehrmann, ... The Lancet Oncology 22 (12), 1681-1691, 2021 | 146 | 2021 |
| The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a … JSF Sanders, FJ Bemelman, AL Messchendorp, CC Baan, D van Baarle, ... Transplantation 106 (4), 821-834, 2022 | 140 | 2022 |
| Successive immunoglobulin and cytokine expression in the small intestine of juvenile chicken A Lammers, WH Wieland, L Kruijt, A Jansma, T Straetemans, A Schots, ... Developmental & Comparative Immunology 34 (12), 1254-1262, 2010 | 132 | 2010 |
| SARS-CoV-2–specific antibody detection for seroepidemiology: a multiplex analysis approach accounting for accurate seroprevalence G den Hartog, RM Schepp, M Kuijer, C GeurtsvanKessel, J van Beek, ... The Journal of infectious diseases 222 (9), 1452-1461, 2020 | 131 | 2020 |
| Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave ERA Vos, G den Hartog, RM Schepp, P Kaaijk, J van Vliet, K Helm, ... J epidemiol community health 75 (6), 489-495, 2021 | 99 | 2021 |
| Persistence of antibodies to severe acute respiratory syndrome coronavirus 2 in relation to symptoms in a nationwide prospective study G den Hartog, ERA Vos, LL van den Hoogen, M van Boven, RM Schepp, ... Clinical Infectious Diseases 73 (12), 2155-2162, 2021 | 95 | 2021 |
| Regulation of Rac1 and Reactive Oxygen Species Production in Response to Infection of Gastrointestinal Epithelia Gerco den Hartog, Ranajoy Chattopadhyay, Amber Ablack, Emily H. Hall ... PLOS Pathogens 12 (1), e1005382, 2016 | 64 | 2016 |
| Berberine and obatoclax inhibit SARS-Cov-2 replication in primary human nasal epithelial cells in vitro FS Varghese, E van Woudenbergh, GJ Overheul, MJ Eleveld, L Kurver, ... Viruses 13 (2), 282, 2021 | 62 | 2021 |
| Antibody response in immunocompromised patients with hematologic cancers who received a 3-dose mRNA-1273 vaccination schedule for COVID-19 S Haggenburg, Q Hofsink, BI Lissenberg-Witte, AEC Broers, ... JAMA oncology 8 (10), 1477-1483, 2022 | 56 | 2022 |
| Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients S Haggenburg, BI Lissenberg-Witte, RS Van BInnendijk, G Den Hartog, ... Blood advances 6 (5), 1537-1546, 2022 | 51 | 2022 |
| Associations between measures of social distancing and severe acute respiratory syndrome coronavirus 2 seropositivity: A nationwide population-based study in the Netherlands ERA Vos, M van Boven, G den Hartog, JA Backer, D Klinkenberg, ... Clinical Infectious Diseases 73 (12), 2318-2321, 2021 | 46* | 2021 |
| Specificity and effector functions of human RSV-specific IgG from bovine milk G den Hartog, S Jacobino, L Bont, L Cox, LH Ulfman, JHW Leusen, ... PloS one 9 (11), e112047, 2014 | 46 | 2014 |
| Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a … MML Kho, AL Messchendorp, SC Frölke, C Imhof, VJCH Koomen, ... The Lancet Infectious Diseases 23 (3), 307-319, 2023 | 44 | 2023 |
| The mucosal factors retinoic acid and TGF-β1 induce phenotypically and functionally distinct dendritic cell types G Den Hartog, C Van Altena, HFJ Savelkoul, RJJ Van Neerven International archives of allergy and immunology 162 (3), 225-236, 2013 | 44 | 2013 |
| Safety and immunogenicity of intradermal fractional dose administration of the mRNA-1273 vaccine: a proof-of-concept study GVT Roozen, MLM Prins, R van Binnendijk, G den Hartog, VP Kuiper, ... Annals of internal medicine 175 (12), 1771-1774, 2022 | 37* | 2022 |
| Decline of RSV-specific antibodies during the COVID-19 pandemic G den Hartog, PB van Kasteren, RM Schepp, AC Teirlinck, ... The Lancet Infectious Diseases 23 (1), 23-25, 2023 | 36 | 2023 |
| Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination? LL van den Hoogen, G Smits, CCE van Hagen, D Wong, ERA Vos, ... Vaccine 40 (15), 2251-2257, 2022 | 35 | 2022 |
| Modulation of Human Immune Responses by Bovine Interleukin-10 G den Hartog, HFJ Savelkoul, R Schoemaker, E Tijhaar, AH Westphal, ... PloS one 6 (3), e18188, 2011 | 35 | 2011 |
Corine H. GeurtsvanKesselErasmus MC ViroscienceVerified email at erasmusmc.nl
